garenoxacin has been researched along with Endocarditis, Bacterial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Entenza, JM; Glauser, MP; Moreillon, P; Vouillamoz, J | 1 |
| Anguita-Alonso, P; Patel, R; Piper, KE; Rouse, MS; Steckelberg, JM | 1 |
2 other study(ies) available for garenoxacin and Endocarditis, Bacterial
| Article | Year |
|---|---|
Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Floxacillin; Fluoroquinolones; Infusions, Intravenous; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rats; Staphylococcal Infections; Streptococcal Infections; Vancomycin; Viridans Streptococci | 2004 |
Garenoxacin treatment of experimental endocarditis caused by viridans group streptococci.
Topics: Animals; Anti-Bacterial Agents; Endocarditis, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests; Rabbits; Streptococcal Infections; Viridans Streptococci | 2006 |